Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women
Public ClinicalTrials.gov record NCT00406640. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, 8-Week Double-Blind Acute Phase Followed By a 6-Month Continuation Phase (Open-Label Or Double-Blind) Study to Evaluate the Efficacy, Safety, and Tolerability of DVS SR Versus Escitalopram in Postmenopausal Women With Major Depressive Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Desvenlafaxine succinate (DVS) is a potent and selective serotonin and norepinephrine reuptake inhibitor (SNRI). This study will investigate the safety, efficacy, and tolerability of DVS SR versus escitalopram in women with major depressive disorder (MDD) who are postmenopausal.
Study identification
- NCT ID
- NCT00406640
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 595 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 40 Years to 70 Years
- Sex
- Female
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2006 (Type not available)
- Primary completion
- Feb 2008 (Actual)
- Completion
- Oct 2008 (Actual)
- Last update posted
- Dec 28, 2023
2006 – 2008
United States locations
- U.S. sites
- 52
- U.S. states
- 26
- U.S. cities
- 49
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Peoria | Arizona | 85381 | — |
| Not listed | Pasadena | California | 91107 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92108 | — |
| Not listed | Denver | Colorado | 80212 | — |
| Not listed | Cromwell | Connecticut | 06416 | — |
| Not listed | Farmington | Connecticut | 06030 | — |
| Not listed | Waterbury | Connecticut | 06708 | — |
| Not listed | Brooksville | Florida | 34613 | — |
| Not listed | Coral Springs | Florida | 33065 | — |
| Not listed | Fort Myers | Florida | 33912 | — |
| Not listed | Gainesville | Florida | 32607 | — |
| Not listed | Maitland | Florida | 32751 | — |
| Not listed | Atlanta | Georgia | 30328 | — |
| Not listed | Roswell | Georgia | 30076 | — |
| Not listed | Northfield | Illinois | 60093 | — |
| Not listed | Oak Brook | Illinois | 60523 | — |
| Not listed | Overland Park | Kansas | 66211 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | New Orleans | Louisiana | 70115 | — |
| Not listed | Shreveport | Louisiana | 71130 | — |
| Not listed | Baltimore | Maryland | 21208 | — |
| Not listed | Boston | Massachusetts | 02114 | — |
| Not listed | Fall River | Massachusetts | 02721 | — |
| Not listed | Saint Paul | Minnesota | 55101 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Piscataway | New Jersey | 08854 | — |
| Not listed | Elmsford | New York | 10523 | — |
| Not listed | Hollis | New York | 11423 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | New York | New York | 10128 | — |
| Not listed | Syracuse | New York | 13210 | — |
| Not listed | Raleigh | North Carolina | 27612 | — |
| Not listed | Oklahoma City | Oklahoma | 73103 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Pittsburgh | Pennsylvania | 15206 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | East Providence | Rhode Island | 02914 | — |
| Not listed | Lincoln | Rhode Island | 02865 | — |
| Not listed | Charleston | South Carolina | 29407 | — |
| Not listed | Columbia | South Carolina | 29201 | — |
| Not listed | Mt. Pleasant | South Carolina | 29464 | — |
| Not listed | Memphis | Tennessee | 38117 | — |
| Not listed | Bellaire | Texas | 77401 | — |
| Not listed | Dallas | Texas | 75235 | — |
| Not listed | Denton | Texas | 76201 | — |
| Not listed | Houston | Texas | 77090 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Charlottesville | Virginia | 22903 | — |
| Not listed | Richmond | Virginia | 23230 | — |
| Not listed | Morgantown | West Virginia | 26506 | — |
| Not listed | Middleton | Wisconsin | 53562 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 18 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00406640, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2023 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00406640 live on ClinicalTrials.gov.